Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
Sustainable infrastructure investment firm Generate Capital has garnered $2 billion in investments from some of the world’s largest institutions. The capital raise, expected to be announced Monday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results